Wellington Management Group
CLVS

Wellington Management Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Wellington Management Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-325
Closed -$462K – 2358
2017
Q4 		$462K Buy
+325
New +$22.7K ﹤0.01% 2059

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Wellington Management Group's CLVS Position: Q4 2022 in Review

Wellington Management Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 560,565 shares — an estimated $667K sold.

Wellington Management Group first reported a position in CLVS in Q3 2016 and held it in 13 quarters. The position peaked at $84.8M in Q1 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Wellington Management Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wellington Management Group sold 560,565 Clovis Oncology, Inc. shares in Q4 2022, an estimated $667K.
  • Wellington Management Group first reported a position in Clovis Oncology, Inc. in Q3 2016 and held it in 13 quarters.
  • Wellington Management Group's Clovis Oncology, Inc. position peaked at $84.8M in Q1 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.